alpha-aminopyridine has been researched along with Adrenocortical Hyperfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LL; Wang, PS; Wun, WA | 1 |
| Chang, LL; Wang, PS; Wun, WS | 1 |
2 other study(ies) available for alpha-aminopyridine and Adrenocortical Hyperfunction
| Article | Year |
|---|---|
An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adipose Tissue; Adiposity; Adrenocortical Hyperfunction; Aldosterone; Aminopyridines; Animals; Cells, Cultured; Corticosterone; Fatty Acid Synthase, Type I; Female; Humans; Liver; Phenols; PPAR alpha; PPAR gamma; Pregnancy; Rats, Sprague-Dawley; Sulfonamides | 2018 |
Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-β hydroxysteroid dehydrogenase type 1.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiponectin; Adipose Tissue; Adrenal Glands; Adrenocortical Hyperfunction; Aldosterone; Aminopyridines; Animals; Corticosterone; Female; Liver; Male; Phenols; PPAR alpha; Pregnancy; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides | 2016 |